Back to company

UNIPHARMA ApS: Financial statements 2020

CVR: 78881917

UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK -5,000 and a net result of DKK -5,000 compared with DKK -5,000 the year before. Equity amounted to DKK 61,735. The solvency ratio was 34.2%.

Revenue
-5,000 kr.
Gross Profit
-5,000 kr.
Profit/Loss
-5,000 kr.
Equity
61,735 kr.
Total Assets
180,490 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-5 t.-5 t.-5 t.62 t.-
2019-5 t.-5 t.-5 t.67 t.-
2018-10 t.-10 t.-10 t.72 t.-
2017-9 t.-9 t.-9 t.73 t.-
2016--11 t.-11 t.82 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is UNIPHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

UNIPHARMA ApS: The 2019 annual report is outOct 16, 2020

UNIPHARMA ApS has published its annual report for 2019. Revenue came to DKK -5,000, and the net result was DKK -5,000.

About UNIPHARMA ApS

UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.